Hisamitsu Pharmaceutical Co Inc - Company Profile
Powered by 
All the sales intelligence you need on Hisamitsu Pharmaceutical Co Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Hisamitsu Pharmaceutical Co Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Hisamitsu Pharmaceutical Co Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain-relieving products, dermatological products and quasi-drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms such as patches, gel patches, gels, creams, and lotions. Its products are indicated for the relief of sore shoulders, arthritis, joint pain, back pain, strains, sprains, stiff neck, muscle fatigue, bruises, and muscle pain, among other conditions. It operates production facilities, research laboratories, and offices in Japan and serves both over-the-counter (OTC) and prescription markets. The company markets its products in Asia and the US. Hisamitsu Pharmaceutical is headquartered in Chiyoda-Ku, Tokyo, Japan.
Headquarters
Japan
Address
30F Marunouchi Building, 2-4-1 Marunouchi, Chiyoda-Ku, Tokyo, 100-6330
Website
www.hisamitsu.co.jp
Telephone
81 3 52931700
No of Employees
2,759
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4530 (TYO)
Revenue (2025)
$1.0B
EPS
XYZ
Market Cap*
$2.9B
Net Profit Margin (2025)
XYZ
41.5%
* As of and is in US$
Hisamitsu Pharmaceutical Co Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | - | - |
| Anti-Inflammatory Pain Relieving Patches | Export of Products | Salonpas |
| Antifungal Drugs | Nobinobi Salonsip | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In July, the company signed a joint development and licensing agreement in Japan with TOYO Pharmaceutical Co., Ltd. for a gel formulation used to relieve pain associated with postherpetic neuralgia. |
| 2024 | Financing Agreements | In December, the company invested in Re-Eir, a biotech startup. |
| 2024 | New Products/Services | In April, the company launched a pain management product Salonpas in Nigeria. |
Competitor Comparison
| Key Parameters | Hisamitsu Pharmaceutical Co Inc | Teva Pharmaceutical Industries Ltd | Daiichi Sankyo Co Ltd | Kaken Pharmaceutical Co Ltd | Zeria Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Israel | Japan | Japan | Japan |
| City | Chiyoda-Ku | Tel Aviv | Chuo-Ku | Bunkyo-Ku | Chuo-Ku |
| State/Province | Tokyo | Tel Aviv | Tokyo | Tokyo | Tokyo |
| No. of Employees | 2,759 | 31,173 | 19,765 | 1,126 | 1,746 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kazuhide Nakatomi | Chief Executive Officer; President | Senior Management | 2015 | 52 |
| Nobuo Tsutsumi | Director - Legal Affairs, Production Environment, Reliability Assurance, and Compliance | Senior Management | 2024 | - |
| Hisashi Saito | Head - Global Business; Managing Director | Senior Management | 2023 | - |
| Koji Takiyama | Director - President | Senior Management | 2022 | 53 |
| Shinichi Murayama | Director - Internal Control and Domestic Subsidiaries | Senior Management | 2023 | 57 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer